Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell.

BMC Microbiology
Sofia Costa-de-OliveiraAcácio Gonçalves Rodrigues

Abstract

The administration of non-antifungal drugs during patient hospitalization might be responsible for discrepancies between in vitro and in vivo susceptibility to antifungals. Propofol is often administered to intensive care units as a sedative. The purpose of this study was to evaluate the effect of propofol lipidic infusion upon the growth and susceptibility profile of pathogenic fungi. Candida and Aspergillus were studied regarding the ability to grow and its susceptibility profile to antifungals in the presence of propofol infusion (Fresenius(R)) (1.25, 2.5 and 5 mg.ml-1) and its lipidic vehicle. The intensity of fluorescence after staining with FUN1, in the presence and absence of propofol infusion, was determined by flow cytometry. Radioactivity assays were also performed in order to quantify the input of [3H]- itraconazole into the fungal cell in the presence of propofol. Assays were repeated after addition of sodium azide, in order to block efflux pumps. Propofol infusion promoted budding of Candida and the germination of Aspergillus, latter forming a lipid layer around the hypha. An increase of minimal fungicidal concentrations regarding both Candida and Aspergillus strains was found for all antifungals when incubated sim...Continue Reading

References

Jul 1, 1995·Anesthesia and Analgesia·M B SosisE Villaflor
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexE J Anaissie
Jul 20, 1995·The New England Journal of Medicine·S N BennettL Stroud
Nov 1, 1996·Acta Anaesthesiologica Scandinavica·A Bach, J Motsch
Dec 12, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Pina-VazJ Martinez-de-Oliveira
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Kasturi MukhopadhyayRajendra Prasad
Mar 29, 2003·Diagnostic Microbiology and Infectious Disease·Emilia CantónAna Espinel-Ingroff
Sep 15, 2004·Journal of Clinical Microbiology·Ricardo Araujo, Acacio Gonçalves Rodrigues
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Quanbo XiongSeiichi P T Matsuda
Feb 21, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·G Chamilos, D P Kontoyiannis
Dec 26, 2006·International Journal of Antimicrobial Agents·Ricardo AraujoAcacio Gonçalves Rodrigues

❮ Previous
Next ❯

Citations

Feb 3, 2015·Revista iberoamericana de micología·Tatiane BenaducciMaria José Soares Mendes-Giannini
Jul 11, 2016·Revista iberoamericana de micología·Ana Isabel RenauMiguel Salavert
May 29, 2014·Antimicrobial Agents and Chemotherapy·Elisabete RicardoCidália Pina-Vaz
Jan 26, 2020·Microorganisms·Sofia Costa-de-Oliveira, Acácio G Rodrigues

❮ Previous
Next ❯

Methods Mentioned

BETA
phase
flow cytometry

Software Mentioned

SPSS

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.